Sedana Medical
SEDANA | ST
Overview
Corporate Details
- ISIN(s):
- SE0015988373
- LEI:
- 549300FQ3NJRI56LCX32
- Country:
- Sweden
- Address:
- Svärdvägen 3A, 182 33 DANDERYD
- Website:
- https://sedanamedical.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Sedana Medical is a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient’s life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical product Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, the Nordic, and Spain. In other parts of Europe as well as in Asia, Australia, Canada, and South- and Central America, the company works with external distributors. Sedana Medical was founded in 2005, is listed on Nasdaq Stockholm and is headquartered in Stockholm, Sweden.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-18 07:00 |
Earnings Release
|
Swedish | 1.2 MB | |
| 2025-07-18 07:00 |
Earnings Release
|
English | 1.1 MB | |
| 2025-05-15 17:00 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från Sedana Medical AB:s årsstämma den 15 maj 2025
|
Swedish | 100.9 KB | |
| 2025-05-15 17:00 |
Declaration of Voting Results & Voting Rights Announcements
Report from Sedana Medical AB’s annual general meeting on 15 May 2025
|
English | 99.6 KB | |
| 2025-05-06 07:00 |
Earnings Release
|
Swedish | 1.1 MB | |
| 2025-05-06 07:00 |
Earnings Release
|
English | 971.5 KB | |
| 2025-02-13 07:01 |
Earnings Release
|
Swedish | 1.2 MB | |
| 2025-02-13 07:01 |
Earnings Release
|
English | 1.0 MB | |
| 2025-02-12 17:30 |
Inside Information Statement
Sedana Medical announces positive high-level results also for its second pivota…
|
English | 110.3 KB | |
| 2025-02-12 17:30 |
Inside Information Statement
Sedana Medical meddelar positiva topline-resultat även för bolagets andra pivot…
|
Swedish | 110.8 KB | |
| 2025-02-03 17:30 |
Regulatory News Service
Sedana Medical erhåller ytterligare ett års marknadsskydd för Sedaconda® (isofl…
|
Swedish | 108.1 KB | |
| 2025-02-03 17:30 |
Regulatory News Service
Sedana Medical receives an additional year of market protection for Sedaconda® …
|
English | 107.5 KB | |
| 2024-12-19 19:59 |
Inside Information Statement
Sedana Medical announces positive high-level results of its first pivotal trial…
|
English | 108.3 KB | |
| 2024-12-19 19:59 |
Inside Information Statement
Sedana Medical meddelar positiva topline-resultat från bolagets första pivotala…
|
Swedish | 108.6 KB | |
| 2024-12-13 17:35 |
Regulatory News Service
Sedana Medical erhåller positivt besked att inkludera barn (3-17 år) i indikati…
|
Swedish | 109.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-18 | Christoffer Björn Rosenblad | Other | Buy | 10,000 | 101,000.00 SEK |
| 2024-11-04 | Claus Bjerre | Other | Buy | 125,000 | 1,475,000.00 SEK |
| 2022-08-29 | Christoffer Björn Rosenblad | Other | Buy | 10,000 | 232,000.00 SEK |
| 2022-08-29 | Christoffer Björn Rosenblad | Other | Sell | 5,000 | 115,000.00 SEK |
| 2022-07-21 | Hilde Furberg | Other | Buy | 3,000 | 64,288.44 SEK |
| 2022-04-28 | Johan Spetz | Other | Buy | 6,461 | 223,615.21 SEK |
| 2022-04-28 | Johannes Doll | Other | Buy | 6,000 | 209,520.60 SEK |
| 2022-04-28 | Christoffer Björn Rosenblad | Other | Buy | 5,000 | 161,400.00 SEK |
| 2021-12-03 | Johannes Doll | Other | Buy | 11,630 | 1,000,180.00 SEK |
| 2021-09-20 | Ola Gunnar Magnusson | Other | Sell | 30,000 | 2,943,000.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
DanCann Pharma A/S | Denmark | DANCAN | |
|
DARWIN AG | Germany | 7V0 | |
|
Dechra Pharmaceuticals PLC | United Kingdom | DPH | |
|
Dermapharm Holding SE | Germany | DMP | |
|
Dicot Pharma AB | Sweden | DICOTBT | |
|
EARNZ PLC | United Kingdom | EARN | |
|
Eevia Health Plc | Finland | EEVIA | |
|
Egetis Therapeutics | Sweden | EGTX | |
|
ELARIS AG | Germany | ELS | |
|
Enervit | Italy | ENV |